PERSPECTA

News from every angle

← Back to headlines

Alnylam Pharmaceuticals Achieves Free Cash Flow Breakeven in 2025

Alnylam Pharmaceuticals has successfully achieved free cash flow breakeven in 2025, marking a significant financial milestone for the company.

9 Apr, 14:22 — 9 Apr, 14:22
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual137d ago

Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025

Read full article →

Related Stories

UK Invests £71 Million to Reopen Devon Tungsten Mine

22m ago

eGain and High Tide to Announce Q4 and Q3 2026 Financial Results

41m ago

TCS to Acquire Porsche's MHP Subsidiary for €320 Million

1h ago

Budget: Primary surplus of €5.77 billion in the first seven months of the year

2h ago